Expression of biologically active rat apolipoprotein AIV in Escherichia coli

Physiology and Behavior

Volumn 78, Issue 1, 2003, Pages 149-155

  Liu, Min ^a   Maiorano, Nick ^a   Shen, Ling ^a   Pearson, Kevin ^a   Tajima, Daisuke ^a   Zhang, Dian Ming ^a   Woods, Stephen C ^a   Seeley, Randy J ^a   Davidson, W Sean ^a   Tso, Patrick ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Apolipoprotein A IV; Escherichia coli; Food intake; Recombinant expression

Indexed keywords

APOLIPOPROTEIN A4;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL CELL; BINDING ASSAY; CONDITIONING; ESCHERICHIA COLI; FOOD INTAKE; IMMUNOBLOTTING; MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; TASTE AVERSION;

EID: 12244277609     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(02)00959-9     Document Type: Article

References (22)

1. Boguski M.S., Elshourbagy N., Taylor J.M., Gordon J.I. Rat apolipoprotein A-IV contains 13 tandem repetitions of a 22-amino acid segment with amphipathic helical potential. Proc. Natl. Acad. Sci. U. S. A. 81:1984;5021-5025.
2. Davidson W.S., Rodrigueza W.V., Lund-Katz S., Johnson W.J., Rothblat G.H., Phillips M.C. Effects of acceptor particle size on the efflux of cellular free cholesterol. J. Biol. Chem. 270:1995;17106-17113.
3. Duverger N., Tremp G., Caillaud J.M., Emmanuel F., Castro G., Fruchart J.C.et al. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science. 273:1996;966-968.
4. Dvorin E., Gorder N.L., Benson D.M., Gotto A.M. Jr. Apolipoprotein A-IV. A determinant for binding and uptake of high density lipoproteins by rat hepatocytes. J. Biol. Chem. 261:1986;15714-15718.
5. Fujimoto K., Cardelli J.A., Tso P. Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am. J. Physiol. 262:1992;G1002-G1006.
6. Fujimoto K., Fukagawa K., Sakata T., Tso P. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J. Clin. Invest. 91:1993;1830-1833.
7. Fujimoto K., Machidori H., Iwakiri R., Yamamoto K., Fujisaki J., Sakata T.et al. Effect of intravenous administration of apolipoprotein A-IV on patterns of feeding, drinking and ambulatory activity of rats. Brain Res. 608:1993;233-237.
8. Goldberg I.J., Scheraldi C.A., Yacoub L.K., Saxena U., Bisgaier C.L. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J. Biol. Chem. 265:1990;4266-4272.
9. Green P.H., Glickman R.M., Riley J.W., Quinet E. Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J. Clin. Invest. 65:1980;911-919.
10. Hayashi H., Nutting D.F., Fujimoto K., Cardelli J.A., Black D., Tso P. Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat. J. Lipid Res. 31:1990;1613-1625.
11. Jonas A. Reconstitution of high-density lipoproteins. Methods Enzymol. 128:1986;553-582.
12. Jonas A., Kezdy K.E., Wald J.H. Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. J. Biol. Chem. 264:1989;4818-4824.
13. Liu M., Doi T., Shen L., Woods S.C., Seeley R.J., Zheng S.et al. Intestinal satiety protein apolipoprotein AIV is synthesized and regulated in rat hypothalamus. Am. J. Physiol. 280:2001;R1382-R1387.
14. Markwell M.A., Haas S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87:1978;206-210.
15. Okumura T., Fukagawa K., Tso P., Taylor I.L., Pappas T.N. Intracisternal injection of apolipoprotein A-IV inhibits gastric secretion in pylorus-ligated conscious rats. Gastroenterology. 107:1994;1861-1864.
16. Okumura T., Taylor I.L., Fukagawa K., Tso P., Pappas T.N. Apolipoprotein A-IV acts centrally in the brain to reduce the severity of gastric ulceration in the rat. Brain Res. 673:1995;153-156.
17. Ostos M.A., Conconi M., Vergnes L., Baroukh N., Ribalta J., Girona J.et al. Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21:2001;1023-1028.
18. Panagotopulos S.E., Horace E.M., Maiorano J.N., Davidson W.S. Apolipoprotein A-I adopts a belt-like orientation in reconstituted high density lipoproteins. J. Biol. Chem. 276:2001;42965-42970.
19. Qin X., Swertfeger D.K., Zheng S., Hui D.Y., Tso P. Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am. J. Physiol. 274:1998;H1836-H1840.
20. Sparks D.L., Phillips M.C. Quantitative measurement of lipoprotein surface charge by agarose gel electrophoresis. J. Lipid Res. 33:1992;123-130.
21. Thiele T.E., van Dijk G., Campfield L.A., Smith F.J., Burn P., Woods S.C.et al. Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats. Am. J. Physiol. 272:1997;R726-R730.
22. Wu A.L., Windmueller H.G. Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat. J. Biol. Chem. 254:1979;7316-7322.